Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Adherence and Viral Load in HIV Patients on First-Time PI Regimens (Kaletra vs Others)
NCT00234962Phase 4Terminated
- Sponsor
- Abbott Laboratories
- Start
- Aug 2002
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 4, open-label trial of lopinavir + ritonavir in human immunodeficiency virus infection (HIV) (2 cohorts), sponsored by Abbott Laboratories. Primary endpoint: Antiviral efficacy by HIV RNA. Started Aug 2002; status: terminated.
02
Drugs
lopinavir + ritonavir
03
Conditions
human immunodeficiency virus infection (HIV)
Beyond the preview
Go deeper on NCT00234962.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00234962.